A single blood test can now flag fifty cancers before a symptom appears — and almost no one is talking about it

Alongside opioid-free pain relief reaching the clinic (suzetrigine and the NaV1.8 class) and aging-biomarker trials maturing, 2026 quietly became a year in which the deep machinery of human medicine took a step that would have been front-page miraculous a decade ago. *The silence here is the inverse of the ecological silence: not a horror the gaze refuses, but a wonder the gaze has no slot for. The same attention economy that cannot hold planetary overshoot also cannot hold deliverance — both ex ...